TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
Scanbio Ingredients AS
Closing information (x1000 EUR)
| Closing information | 2022/12 | 2021/12 | 2020/12 |
| Turnover |
71,310
|
62,439
|
50,512 |
| Financial expenses |
10,540
|
7,918
|
6,453 |
| Earnings before taxes |
10,079
|
-2,027
|
1,411 |
| Total assets |
51,073
|
35,550
|
35,148 |
| Current assets |
39,142
|
21,257
|
17,329 |
| Current liabilities |
17,589
|
15,814
|
15,685 |
| Equity capital |
33,418
|
19,736
|
19,347 |
| - share capital |
22,610
|
23,863
|
22,634 |
Financial ratios
| Fiscal year | 2022/12 | 2021/12 | 2020/12 |
| Solvency |
65.4%
|
55.5%
|
55.0% |
| Turnover per employee | |||
| Profit as a percentage of turnover |
14.1%
|
-3.2%
|
2.8% |
| Return on assets (ROA) |
40.4%
|
16.6%
|
22.4% |
| Current ratio |
222.5%
|
134.4%
|
110.5% |
| Return on equity (ROE) |
30.2%
|
-10.3%
|
7.3% |
| Change turnover |
12,151
|
9,183
|
1,981 |
| Change turnover % |
21%
|
17%
|
4% |
| Chg. No. of employees | |||
| Chg. No. of employees % |
Total value of public sale
| Fiscal year | 2022/12 | 2021/12 | 2020/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.